VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HCSG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HCSGHealthcare Services Group, Inc.
$24.62$1.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksHCSGFinancials

Healthcare Services Group, Inc. (HCSG) Financials

30Y historyFree accessUpdated daily

Revenue growth remains modest at 3.4% as of 2026Q1, though gross margins continue to exhibit extreme volatility, swinging from a low of 0.6% in 2025Q2 to 16.4% in 2026Q1.

HCSG Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue1.85B1.84B1.72B1.67B1.69B1.64B1.76B1.84B2.01B1.87B1.56B1.44B1.29B1.15B1.08B889.07M773.96M692.7M602.72M577.72M511.63M466.29M442.57M379.72M328.5M284.19M254.67M232.4M204.9M181.4M162.5M
Revenue Growth %6.46%7.08%2.65%-1.11%2.94%-6.72%-4.37%-8.37%7.65%19.42%8.76%11.11%12.46%6.72%21.19%14.87%11.73%14.93%4.33%12.92%9.72%5.36%16.55%15.59%15.59%11.59%9.58%13.42%12.95%11.63%9.28%
Cost of Goods Sold1.6B1.6B1.49B1.46B1.5B1.41B1.49B1.61B1.77B1.61B1.34B1.24B1.16B995.1M930.81M766.96M665.15M597.72M521.27M493.36M438.62M406.11M388.72M334.61M289.86M252.03M226.9M203.6M172.3M152.3M137M
COGS % of Revenue-86.97%86.71%87.15%88.56%85.96%84.78%87.62%88.21%86.41%85.72%86.03%89.34%86.54%86.39%86.27%85.94%86.29%86.49%85.4%85.73%87.09%87.83%88.12%88.24%88.68%89.1%87.61%84.09%83.96%84.31%
Gross Profit251.34M239.41M228.09M214.75M193.31M230.57M267.99M227.9M236.84M253.62M223.17M200.74M137.89M154.79M146.62M122.11M108.81M94.98M81.45M84.36M73.01M60.18M53.85M45.11M38.64M32.16M27.77M28.8M32.6M29.1M25.5M
Gross Margin %13.57%13.03%13.29%12.85%11.44%14.04%15.22%12.38%11.79%13.59%14.28%13.97%10.66%13.46%13.61%13.73%14.06%13.71%13.51%14.6%14.27%12.91%12.17%11.88%11.76%11.32%10.9%12.39%15.91%16.04%15.69%
Gross Profit Growth %-4.96%6.21%11.09%-16.16%-13.96%17.59%-3.77%-6.62%13.64%11.17%45.58%-10.92%5.57%20.08%12.22%14.56%16.61%-3.45%15.54%21.33%11.75%19.38%16.74%20.15%15.81%-3.58%-11.66%12.03%14.12%6.25%
Operating Expenses183.96M190.87M174.82M160.09M149.52M166.43M267.99M150.02M136.6M126.73M105.42M111.69M107.81M92M79.28M65.31M57.31M50.27M39.52M40.28M37.2M32.58M31.52M29.04M25.15M21.87M19.62M20.9M19.5M19.8M15.2M
OpEx % of Revenue-10.39%10.19%9.58%8.85%10.14%15.22%8.15%6.8%6.79%6.75%7.77%8.34%8%7.36%7.35%7.4%7.26%6.56%6.97%7.27%6.99%7.12%7.65%7.66%7.7%7.7%8.99%9.52%10.92%9.35%
Selling, General & Admin183.96M190.87M174.82M160.09M149.52M166.43M141.58M150.02M136.6M126.73M105.42M111.69M107.81M92M79.28M65.31M57.31M50.27M39.52M40.28M37.2M32.58M31.52M29.04M25.15M21.87M19.62M18.8M17.4M17.7M13M
SG&A % of Revenue-10.39%10.19%9.58%8.85%10.14%8.04%8.15%6.8%6.79%6.75%7.77%8.34%8%7.36%7.35%7.4%7.26%6.56%6.97%7.27%6.99%7.12%7.65%7.66%7.7%7.7%8.09%8.49%9.76%8%
Research & Development0000000000000000000000000000000
R&D % of Revenue-------------------------------
Other Operating Expenses000000126.41M0000-62K0000000000000002.1M2.1M2.1M2.2M
Operating Income67.38M48.54M53.27M54.66M43.79M64.13M077.88M100.24M126.89M117.75M89.05M30.08M62.79M67.34M56.8M51.5M44.71M41.93M44.07M35.82M27.6M22.33M16.06M13.49M10.29M8.15M7.9M13.1M9.3M10.3M
Operating Margin %3.64%2.64%3.1%3.27%2.59%3.91%-4.23%4.99%6.8%7.54%6.2%2.33%5.46%6.25%6.39%6.65%6.45%6.96%7.63%7%5.92%5.04%4.23%4.11%3.62%3.2%3.4%6.39%5.13%6.34%
Operating Income Growth %--8.88%-2.54%24.82%-31.72%--100%-22.31%-21%7.76%32.23%196.05%-52.09%-6.77%18.56%10.3%15.18%6.64%-4.87%23.05%29.77%23.63%38.98%19.05%31.16%26.23%3.16%-39.69%40.86%-9.71%8.42%
EBITDA84.08M65.32M67.86M69M59.1M78.8M144.83M91.82M109.51M135.78M125.25M96.71M37.35M68.99M72.46M61.19M55.26M47.94M44.78M47.08M38.12M29.47M24.2M17.98M15.53M12.53M10.36M10M15.2M11.4M12.5M
EBITDA Margin %4.54%3.56%3.96%4.13%3.5%4.8%8.23%4.99%5.45%7.28%8.02%6.73%2.89%6%6.73%6.88%7.14%6.92%7.43%8.15%7.45%6.32%5.47%4.73%4.73%4.41%4.07%4.3%7.42%6.28%7.69%
EBITDA Growth %23.59%-3.74%-1.66%16.74%-24.99%-45.59%57.73%-16.15%-19.35%8.4%29.51%158.94%-45.86%-4.79%18.42%10.73%15.27%7.06%-4.88%23.48%29.35%21.79%34.6%15.79%23.92%20.94%3.6%-34.21%33.33%-8.8%3.31%
D&A (Non-Cash Add-back)16.71M16.78M14.59M14.34M15.32M14.67M14.27M13.94M9.27M8.89M7.5M7.66M7.27M6.2M5.12M4.39M3.76M3.23M2.85M3M2.31M1.87M1.87M1.91M2.03M2.24M2.21M2.1M2.1M2.1M2.2M
EBIT79.7M69.45M59.38M60.91M47.54M66.9M130.56M88.56M103M134.33M119.25M88.99M31.29M65.79M69.06M56.7M52.82M44.71M41.93M44.07M35.82M27.6M22.38M16.06M13.49M10.29M8.15M7.9M13.1M9.3M10.3M
Net Interest Income-1.97M-1.58M-6.44M-7.86M-2.99M-1.39M-1.37M-3.46M-3.09M-1.36M000000000000000000000
Interest Income0000000000000000000000000000000
Interest Expense1.97M1.58M6.44M7.86M2.99M1.39M1.37M3.46M3.09M1.36M000000000000000000000
Other Income/Expense11.14M19.33M-330K-1.6M764K1.38M129.19M7.22M2.07M6.08M2.63M712K1.63M3.7M1.2M1.01M2.62M4.62M1.35M4.02M4.91M3.2M1.33M1.45M771.47K1.25M988.9K800K1.3M1.4M1.2M
Pretax Income78.51M67.87M52.94M53.06M44.55M65.51M129.19M85.1M99.91M132.97M120.39M89.76M31.71M66.49M70.26M57.81M54.12M49.34M43.27M48.09M40.72M30.8M23.71M17.51M14.26M11.54M9.14M8.7M14.4M10.7M11.5M
Pretax Margin %4.24%3.69%3.09%3.17%2.64%3.99%7.34%4.62%4.97%7.13%7.7%6.25%2.45%5.78%6.52%6.5%6.99%7.12%7.18%8.33%7.96%6.61%5.36%4.61%4.34%4.06%3.59%3.74%7.03%5.9%7.08%
Income Tax10.62M8.81M13.47M14.67M10.31M16.97M30.5M20.52M16.39M44.74M42.99M31.74M9.86M19.36M26.05M19.66M19.68M18.99M16.66M18.52M15.27M11.7M9.01M6.66M5.63M4.5M3.55M3.2M5.5M4.8M4.6M
Effective Tax Rate %13.53%12.98%25.44%27.65%23.14%25.9%23.61%24.11%16.4%33.65%35.71%35.36%31.09%29.12%37.07%34%36.36%38.5%38.5%38.5%37.5%38%37.99%38%39.5%39.01%38.86%36.78%38.19%44.86%40%
Net Income67.89M59.06M39.47M38.39M34.24M48.54M98.68M64.58M83.52M88.23M77.4M58.02M21.85M47.13M44.21M38.16M34.44M30.34M26.61M29.58M25.45M19.1M14.7M10.86M8.63M7.04M5.59M5.5M8.9M5.9M6.9M
Net Margin %3.67%3.21%2.3%2.3%2.03%2.96%5.61%3.51%4.16%4.73%4.95%4.04%1.69%4.1%4.1%4.29%4.45%4.38%4.42%5.12%4.97%4.1%3.32%2.86%2.63%2.48%2.19%2.37%4.34%3.25%4.25%
Net Income Growth %64.03%49.63%2.83%12.1%-29.46%-50.81%52.8%-22.68%-5.33%13.99%33.39%165.56%-53.64%6.59%15.88%10.79%13.51%14.01%-10.02%16.21%33.28%29.91%35.35%25.83%22.68%25.91%1.6%-38.2%50.85%-14.49%76.92%
Net Income (Continuing)67.89M59.06M39.47M38.39M34.24M48.54M98.68M64.58M83.52M88.23M77.4M58.02M21.85M47.13M44.21M38.16M34.44M30.34M26.61M29.58M25.45M19.1M14.7M10.86M8.63M7.04M5.59M5.5M8.9M5.9M6.9M
Discontinued Operations0000000000000000000000000000000
Minority Interest0000000000000000000000000000000
EPS (Diluted)0.960.810.530.520.460.651.320.871.121.191.050.800.310.670.650.560.510.460.400.450.390.300.240.180.150.130.100.100.150.100.11
EPS Growth %70.92%52.83%1.92%13.04%-29.23%-50.76%51.72%-22.32%-5.88%13.33%31.25%158.06%-53.73%3.08%16.07%9.8%10.87%15%-11.11%15.38%30%25%33.33%20%15.38%30%3.31%-35.47%50%-9.09%74.05%
EPS (Basic)-0.820.540.520.460.651.320.871.131.201.060.810.310.680.650.570.520.470.410.470.410.320.250.190.150.130.100.100.160.100.11
Diluted Shares Outstanding71.05M73.03M73.99M74.34M74.35M74.96M74.78M74.59M74.61M74.35M73.47M72.51M71.34M70.05M68.48M67.58M67.01M66.43M66.04M65.77M64.72M63.72M62.23M60.03M59.18M55.65M55.47M56.82M58.51M58.95M61.81M
Basic Shares Outstanding69.86M72.38M73.75M74.29M74.34M74.82M74.7M74.36M74M73.36M72.75M71.83M70.62M69.21M67.51M66.64M65.92M65.38M64.7M63.43M61.76M60.57M59M57.54M57.02M55.65M55.47M55.69M57.03M57.44M61.81M
Dividend Payout Ratio----185.07%128.19%61.52%91.28%68.48%62.62%68.92%88.54%224.61%99.1%99.73%110.67%114.06%106.28%93.87%59.96%49.61%42.29%31.28%13.71%-------

Key Metrics

Growth RegimeStable
ProfitabilityStrained
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Client solvency and labor costs

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Amidst Structural Constraints

According to recent financial filings, HCSG has maintained a modest revenue growth trajectory, with year-over-year increases peaking at 8.5% in 2025Q3, suggesting that while the company captures incremental volume, its top-line expansion remains tethered to the occupancy levels of its skilled nursing facility client base.

The company's revenue growth appears to be driven by a combination of contract renewals and expansion into the dietary segment, yet the lack of significant acceleration indicates a mature market environment. Investors should monitor whether the current growth rate can be sustained without further margin dilution, as the reliance on evergreen contracts limits the ability to aggressively capture pricing upside.

Volatility Undermines Structural Margin Stability

As reported in quarterly income statements, HCSG's gross margins have exhibited significant volatility, plummeting to 0.6% in 2025Q2 before recovering to 16.4% in 2026Q1, which highlights the extreme sensitivity of the firm's labor-intensive cost structure to unexpected operational disruptions or inflationary spikes in service delivery.

The wide variance in gross margins suggests that the company lacks the pricing power to fully insulate itself from sudden labor cost increases or regulatory compliance burdens. This instability warrants caution, as the thin margin profile leaves little room for error in managing the high-variable-cost model inherent to the housekeeping and dietary segments.

Operating Leverage Constrained by Costs

Based on the provided income statement data, HCSG's operating income has struggled to scale consistently with revenue, as evidenced by the sharp swing to a $41.6 million operating loss in 2025Q2, indicating that the company's SG&A expenses do not provide the expected efficiency gains during periods of revenue pressure.

The inability to maintain consistent operating leverage suggests that the company's overhead is relatively fixed, while its cost of services remains highly sensitive to external labor market conditions. This dynamic implies that profitability is more dependent on managing direct service costs than on achieving economies of scale through administrative efficiency.

Credit Risk and Margin Compression

Financial data suggests that HCSG's reliance on distressed skilled nursing facility operators creates a persistent risk of bad debt, as the company's historical earnings volatility often correlates with periods of margin compression that may be masked by the timing of insurance and credit loss adjustments.

Short-term observers may focus on the company's ability to maintain revenue growth, but the underlying quality of earnings remains questionable given the potential for future impairment of accounts receivable. The market may be underestimating the risk that HCSG's preferred provider status forces it to absorb losses from clients who are increasingly unable to meet their financial obligations.

HCSG — Frequently Asked Questions

Quick answers to the most common questions about buying HCSG stock.

What was Healthcare Services Group, Inc.'s (HCSG) revenue in 2025?

For fiscal year 2025, Healthcare Services Group, Inc. (HCSG) reported total revenue of $1.84B. This represents a 1030.6% increase compared to $162.5M in 1996.

Is Healthcare Services Group, Inc. (HCSG) profitable?

Healthcare Services Group, Inc. (HCSG) is profitable, generating $59.1M in net income for the fiscal year ending 2025 with a net profit margin of 3.2%.

What is Healthcare Services Group, Inc.'s operating profit margin?

Healthcare Services Group, Inc. (HCSG) reported an operating income of $48.5M, resulting in an operating profit margin of 2.6%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Healthcare Services Group, Inc.'s gross profit and gross margin?

Healthcare Services Group, Inc. (HCSG) generated $239.4M in gross profit for the year, representing a gross profit margin of 13.0%. This demonstrates the company's core pricing power and production efficiency.